Key Points
- Buspirone (Buspar) is an anti-anxiety medication used to treat generalized anxiety disorder (GAD) and is considered a second-line treatment after SSRIs and SNRIs.
- It has a delayed onset of action (about 2 weeks), making it ineffective for treating acute panic attacks.
- Unlike benzodiazepines, buspirone does not cause sedation or dependence, making it a safer option for long-term anxiety treatment.
Mechanism of Action
- Buspirone primarily targets serotonin and dopamine receptors, acting as a partial agonist at serotonin (5-HT1A) receptors and a weak antagonist at dopamine (D2) receptors.
- Unlike benzodiazepines, it does not affect GABA receptors, meaning it has less sedative effect and a lower risk of dependence.
- Patients should take buspirone consistently, even if they don't notice immediate effects. Another anxiolytic may be prescribed temporarily until buspirone takes effect.
Indications
- Primarily used to treat Generalized Anxiety Disorder (GAD).
- Considered a second-line pharmacologic treatment for GAD after SSRIs or SNRIs.
- Acts as a non-benzodiazepine anxiolytic, providing relief from chronic anxiety without the sedative effects or dependency risks associated with benzodiazepines.
- Also used to treat anxiety-related depression, often accompanying chronic anxiety.
Side Effects
- Does not cause tolerance or dependence like benzodiazepines.
- Common side effects include dizziness, headache, and mild GI distress (nausea, vomiting, diarrhea). Taking with food can reduce GI upset.
- Compared to benzodiazepines, buspirone has fewer sedative and hypnotic effects, lowering the risk of sedation or sleep issues.
- Grapefruit juice may increase buspirone's levels in the blood, raising the risk of side effects.
- Concurrent use with MAOIs can lead to serotonin syndrome, a potentially life-threatening condition.
